| Literature DB >> 32296402 |
Carla Hernández-Cabanyero1, Eva Sanjuán1, Belén Fouz1, David Pajuelo1, Eva Vallejos-Vidal2,3, Felipe E Reyes-López2, Carmen Amaro1.
Abstract
Vibrio vulnificus is a zoonotic pathogen that lives in temperate, tropical and subtropical aquatic ecosystems whose geographical distribution is expanding due to global warming. The species is genetically variable and only the strains that belong to the zoonotic clonal-complex can cause vibriosis in both humans and fish (being its main host the eel). Interestingly, the severity of the vibriosis in the eel and the human depends largely on the water temperature (highly virulent at 28°C, avirulent at 20°C or below) and on the iron content in the blood, respectively. The objective of this work was to unravel the role of temperature in the adaptation to the host through a transcriptomic and phenotypic approach. To this end, we obtained the transcriptome of a zoonotic strain grown in a minimum medium (CM9) at 20, 25, 28, and 37°C, and confirmed the transcriptomic results by RT-qPCR and phenotypic tests. In addition, we compared the temperature stimulon with those previously obtained for iron and serum (from eel and human, respectively). Our results suggest that warm temperatures activate adaptive traits that would prepare the bacteria for host colonization (metabolism, motility, chemotaxis, and the protease activity) and fish septicemia (iron-uptake from transferrin and production of O-antigen of high molecular weight) in a generalized manner, while environmental iron controls the expression of a host-adapted virulent phenotype (toxins and the production of a protective envelope). Finally, our results confirm that beyond the effect of temperature on the V. vulnificus distribution in the environment, it also has an effect on the infectious capability of this pathogen that must be taken into account to predict the real risk of V. vulnificus infection caused by global warming.Entities:
Keywords: V. vulnificus; host adaptation; microarray; temperature; transcriptome
Year: 2020 PMID: 32296402 PMCID: PMC7137831 DOI: 10.3389/fmicb.2020.00489
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Microarray validation by RT-qPCR.
| Comparisona | Gene | Fold changeb | |
| Array | RT-qPCR | ||
| 25°C vs. 20°C | 2 (+) | 1.3 (=) | |
| 2 (+) | 4.9 (+) | ||
| – | 1.5 (=) | ||
| – | 1.6 (=) | ||
| – | 1.9 (=) | ||
| 28°C vs. 20°C | 14 (++) | 3.6 (+) | |
| −3.1 (−) | −1.2 (=) | ||
| – | 1.7 (=) | ||
| – | 1.3 (=) | ||
| – | 1.9 (=) | ||
| 37°C vs. 20°C | 5.1 (+) | 3.6 (+) | |
| 3.4 (+) | 1.6 (=) | ||
| – | 1.9 (=) | ||
| – | 1.7 (=) | ||
| – | 1.4 (=) | ||
FIGURE 1Growth of V. vulnificus in a minimal medium at different incubation temperature. R99 strain was inoculated in CM9 and incubated with agitation at 20, 25, 28, and 37°C. Growth was followed by measuring the Abs625 at regular time intervals. #: significant differences (P < 0.05) in Abs625 between 20 and 28°C. *: significant differences (P < 0.05) in Abs625 between 25 and 28°C. *∗: significant differences (P < 0.05) in Abs625 between 37 and 28°C.
FIGURE 2Graphical representation of DEGs distribution among V. vulnificus genome in response to temperature. Figure shows the DEGs according to their distribution per regulation category (upregualted, downregulated, or non-regulated) and replicon (two chromosomes and one plasmid). The different categories are represented by color.
FIGURE 3Cellular processes modulated by temperature. Categories of cellular processes affected at each temperature. Cellular processes differentially expressed at iron stimulon, fur regulon and serum regulons are also included.
Selected DEGs for V. vulnificus grown at infective temperatures (25, 28, and 37°C) vs. non-infective temperature (20°C).
| Gene(s)a | 25°Cb | 28°Cc | 37°Cd | Putative function/processe |
| 11.3 | – | 2.3 | Unsatturated fatty acids metabolism | |
| Peptide ABC transporters# | 10.4-2.4 | – | 3.9 | Peptide transport |
| 7.8-2.5 | – | 2.1 | Amino acid biosynthesis | |
| 6.1-4 | – | 2.8 | Amino acid biosynthesis (tryptophan) | |
| C4-dicarboxylate transporters# | 6-2.4 | – | 20.7-2.9 | Dicarboxilate transport |
| 5-2.1 | 2.1 | – | Amino acid metabolism | |
| Ferric iron ABC transporter*# | 3.7 | 3.4-2.3 | 2.6 | Ferric iron transport |
| Long-chain fatty acid transport protein | 3.3 | – | – | Fatty acids transport |
| Vulnibactin biosynthetic genes*# | 3-2.3 | 2.9-2.5 | 2.3 | Vulnibactin biosynthesis and transport |
| 2.7 | −2.1 | – | Amino acid biosynthesis | |
| 2.4 | – | 2.4 | Fatty acids metabolism | |
| Amino acid ABC transporter* | 2.3 | 5.5-2.8 | 13.8-6.2 | Amino acid transport |
| 2.3-2.1 | 8.5 | 2.8 | Amino acid biosynthesis | |
| L-serine dehydratase | 2.3 | – | – | Amino acid metabolism |
| 2.2 | 2 | – | Polyamine transport | |
| PTS system, | 2.1 | – | 3.5 | Aminosugar transport |
| Nitrate ABC transporter | 2.1 | – | – | Nitrogen metabolism |
| 2 | 2 | 2.8 | Fish transferrin binding protein | |
| −2.6 | −(3.4-3.7) | 6.6-3.4 | Ribose ABC transport system | |
| Short chain fatty acids transporter | −2.7 | −2.4 | – | Fatty acids transport |
| −2.9 | −3.1 | – | Maltose/maltodextrin ABC transporter | |
| −3.1 | −2.6 | – | Ribose metabolism | |
| Chitinase proteins | – | 22.3-2.5 | 8.8 | Chitinase activity |
| – | 10.6 | 9.8 | Amino acid biosynthesis | |
| – | 8.4 | – | Glucose metabolism | |
| Succinate-semialdehyde dehydrogenase [NADP+] | – | 8.4 | – | Amino acid degradation |
| – | 6.7 | 8.1 | Permease for nucleoside uptake | |
| – | 5.7 | – | Degradation of DNA for nutrient uptake (competence related) | |
| Zinc ABC transporter | – | 4.5-3.5 | – | Zinc transport |
| Lipase-related proteins | – | 4.2-2.7 | 8-5.3 | Extracellular lipid utilization |
| Phosphate ABC transporter# | – | 3.8-2.6 | 6.6 | Phosphate transport |
| – | 3.1 | 3.9-2.4 | Potassium uptake | |
| – | 3-2.7 | 7.9-2.1 | Oligopeptide transport system permease | |
| – | 2.8 | 3.4 | Potassium uptake | |
| – | 2.7 | – | Amino acid iosynthesis | |
| – | 2.3 | 6.5 | TRAP dicarboxylate transporters | |
| – | 2.3 | – | Amino acid biosynthesis | |
| Ferrous iron transporter B | – | 2 | – | Ferrous iron transport |
| – | −(2.6-3.7) | – | Fatty acids biosynthesis | |
| – | – | 12.8 | Glycogen debranching enzyme | |
| – | – | 10-4 | Amino acid degradation | |
| – | – | 8.3-2.8 | Citrate metabolism | |
| Nitrate reductase cytochrome c550-type subunit* | 2.7 | – | 3 | Nitrite reductase complex subunit |
| – | 22.5-6.7 | 3.9-2.2 | Subunit of the periplasmic nitrite reductase complex | |
| Nitrite reductase subunits | – | 3.5-2.8 | – | Nitrite reductase complex |
| – | – | 23.3 | Formate-dependent nitrite reductase complex | |
| Anaerobic glycerol-3-phosphate dehydrogenase subunits (B, C)# | 4.6-2.2 | – | 4.4-3.7 | Phospholipid biosynthesis/membrane regeneration |
| 3 | 2.3 | – | Resistance to oxidative stress | |
| 2.8 | – | – | Alkyl hydroperoxide reductase protein F. Resistance to oxidative stress | |
| Glutathione S-transferase# | 2.7 | 4.5 | – | Resistance to oxidative stress |
| 2.7 | – | – | Universal stress protein A, involved in DA-damage resistance | |
| 2.5 | – | – | DNA mismatch repair protein | |
| Superoxide dismutase [Cu–Zn] precursor | 2.3 | – | – | Resistance to oxidative stress |
| 2.2 | 4.9 | 3.3 | Phospholipid biosynthesis/membrane regeneration | |
| Phosphoglycerol transferase I*# | 2.2 | 4.2 | – | Phospholipid biosynthesis/membrane regeneration |
| YfgC precursor* | 2.1 | – | – | Outer membrane integrity |
| 2.1 | – | – | Glutathione transport | |
| Permease of the drug/metabolite transporters (DMT)# | 2 | 4.8-2.1 | 11.5-2.3 | Resistance to microcidal compounds |
| Glycerophosphoryl diester phosphodiesterase# | 2 | – | 3.1 | Phospholipid biosynthesis/membrane regeneration |
| −(2-2.3) | −2.1 | – | Stringent starvation proteins | |
| – | 9.5-6.2 | – | Negative regulatory proteins for RpoE, a sigma factor for envelope stress response | |
| – | 8.2 | – | Repressor for resistance to nitrosative stress | |
| – | 7.2 | – | Drug efflux system | |
| – | 5.7 | – | Stress-induced chaperone | |
| Formate efflux transporter*# | – | 4.8 | – | Resistance to microcidal peptides |
| – | 3.7 | – | Cold shock proteins, involved in stress caused by membrane damage | |
| Manganese superoxide dismutase | – | 3.5 | 11 | Resistance to oxidative stress |
| – | 3.4 | – | Anaerobic nitric oxide reductase transcription regulator | |
| – | 3.2 | 4.5 | Excinuclease ABC subunit C for DNA repair | |
| – | 3 | 6.6 | Multiple antibiotic resistance protein | |
| – | 3 | – | Chaperone protein | |
| – | 2.7 | 2.3 | Peptide methionine sulfoxide reductase involved in reparation of oxidized proteins | |
| – | −2.6 | -3.65 | Repressor for organic hydroperoxidase resistance | |
| – | – | 2.1 | Outer membrane integrity | |
| Methyl-accepting chemotaxis protein*# | 8.5-2.4 | 12.8-2.5 | 15.5-2 | Chemotaxis |
| 2.7 | 3.2-2.1 | 4.2-2.1 | Pili MSHA biosynthesis | |
| 2.4-2.2 | 2 | 4.1-3.1 | Flagellar regulatory protein | |
| 2.2-2.1 | 4.1 | 11.9-3.2 | Flagellar basal-body rod proteins | |
| 2.2-2 | 14.1-3.2 | 10 | Flp pili assembly | |
| 2 | 2.2-2.1 | 3.6-2.6 | Flagellar motor activity | |
| Probable type IV pilus assembly FimV-related | −2.4 | −2.4 | – | Pili MSHA |
| – | 27.1 | 3.8 | RNA polymerase sigma factor | |
| – | 8.7 | 2.1 | Flagellar biosynthesis protein | |
| – | 8.5 | 16 | Hook associated protein | |
| – | 7.5-2.8 | 3.6 | Flagellar motor rotation protein | |
| – | 5.8 | 2.1 | Flagellar synthesis regulator | |
| RNA polymerase sigma factor for flagellar operon | – | 5.4 | – | Flagellar biosynthesis |
| – | 4 | – | Accessory colonization factor, putatively involved in motility | |
| – | 3.7 | – | Controls rotational direction of flagella during chemotaxis | |
| – | 3.6-2.3 | 6.5-4 | Flagellin protein | |
| – | 3.3 | – | Chemotaxis protein | |
| Chemotaxis regulator# | – | 3.1 | 5.8 | Transmits chemoreceptor signals to flagellar motor |
| 2 | 5.5-3.3 | – | Capsule biosynthesis | |
| – | 5.1-2.3 | 15.8-5.2 | Capsule biosynthesis | |
| – | −2.8 | – | LPS biosynthesis | |
| – | – | 4.7 | ||
| – | – | 2.3 | LPS biosynthesis | |
| Nitrogen regulation protein NR(I)* | 3.1 | −2.7 | – | Nitrogen starvation |
| 2.6 | 7.9 | – | Involved in transcriptional control of multidrug efflux pumps, pathways for the biosynthesis of antibiotics, response to osmotic stress and toxic chemicals, control of catabolic pathways, differentiation processes, and pathogenicity | |
| 2.5 | – | – | Stress and metabolism management | |
| −2.4 | −2.6 | – | Repressor for aerobic metabolism | |
| – | 9 | – | Repressor for oligogalacturonide metabolism | |
| – | 4.3 | – | Maltose regulon repressor protein | |
| – | 4 | – | Repressor of deoxyribose operon | |
| – | 3.7 | 5.1 | Repressor of biofilm and biofilm related polysaccharide formation | |
| – | 3.6 | – | Involved in quorum sensing pathways | |
| – | 2.9 | – | Histidine kinase for PhoB, involved in phosphate metabolism | |
| – | 2.9 | – | Phosphorelay protein involved in quorum sensing | |
| CRP* | – | 2.9 | 5 | cAMP receptor protein, regulatory protein |
| – | 2.5 | – | Repressor of arginine metabolism | |
| – | −2.6 | – | Autoinducer 2 sensor kinase/phosphatase, involved in quorum sensing | |
| – | – | 2.2 | Involved in quorum sensing pathways | |
| – | – | −2.7 | Repressor for unsaturated fatty acid biosynthesis | |
FIGURE 4Principal component analysis (PCA) 3-D plot of temperature samples. The transcriptomic profile is represented by different colors.
Phenotypic characterization of V. vulnificus grown at different temperatures.
| Condition | Biofilm (Abs540)a | Motility rateb | Cellular-associated polysaccharides (μg/108 cells)c | Proteolytic activity (PU)d |
| 20°C | 0.027 ± 0.002 | 0.24 ± 0.02* | 87.67 ± 0.37* | 12.09 ± 6.65* |
| 25°C | 0.034 ± 0.005 | 1.56 ± 0.08# | 95.37 ± 1.32*# | 6216.17 ± 250.55# |
| 28°C | 0.035 ± 0.016 | 1.40 ± 0.31# | 103.55 ± 2.77# | 6498.76 ± 210.18# |
| 37°C | 0.066 ± 0.048 | 2.46 ± 0.60*# | 108.68 ± 5.92# | 4021.47 ± 181.49*# |
FIGURE 5Chemotaxis toward eel skin mucus in V. vulnificus. Chemotaxis was measured as Chemotactic response (ratio of bacterial numbers in eel skin mucus-capillaries vs. control-capillaries [containing Chemotaxis buffer (ChB)]). Horizontal line marks the borderline between positive and negative chemotaxis. *: significant differences in chemotaxis response toward eel skin mucus at each temperature vs. 20°C (P < 0.05). #: significant differences in chemotaxis response toward eel skin mucus between each temperature and 28°C (P < 0.05).
FIGURE 6Vibrio vulnificus LPS and capsule profiles in response to temperature. R99 strain was grown until mid-log phase in CM9 at 20, 25, 28, and 37°C. Then, cell-associated polysaccharides (LPS + capsule) were extracted with the method of Hitchcock and Brown (1983) and quantified using the Total Carbohydrate Assay Kit (BioVision). Ten μg of cell associated-polysaccharides were separated by SDS-PAGE on discontinuous gels (4% stacking gel, 10% separating gel), transferred to a PVDF membrane, subjected to immunoblot analysis with antibodies against cell-envelopes of R99 according to Pajuelo et al. (2016). MMW, medium molecular weight.
FIGURE 7Life cycle of the zoonotic pathogen V. vulnificus: role of iron and temperature. This figure summarizes the role of iron levels and temperature in the surrounding environment in determining the life strategy of V. vulnificus. The main steps and processes as well as some genes involved are shown. (1) Resuscitation and induction of the viable but non-culturable state (VBNC). As a free living form, the pathogen swifts between a VBNC and a vegetative state depending on nutrient availability as well as on water temperature and salinity. (2) Capsule and flagellum production in the environment. Vegetative bacteria produce a capsule and a polar flagellum when iron, and probably other nutrients, are available. The flagellum production is also controlled by temperature. (3) Host colonization. Motile/unmotile bacteria could be attracted by blood/mucus (chemotaxis) from their susceptible hosts (eels and humans with high iron-levels in the blood) and colonize a wound or fish mucus. Alternatively, bacteria can be uptaken by filtering organisms and infect humans by ingestion and colonize the intestine or can infect humans by diseased fish handling. (4) Septicemia. From the wound or mucosal tissue, the pathogen arrives to the bloodstream; in case of humans with high iron levels, the pathogen produces a capsule, multiplies and secretes the toxins VvhA and RtxA1 that cause the death by a toxic sepsis; in case of an eel, only the cells with the plasmid produce two iron-regulated outer membrane proteins, Fpcrp (fish phagocytosis complement resistance protein) and Ftbp (fish transferrin binding protein) that protect against innate immunity (in addition to an envelope enriched in O-antigen), multiply and secrete VvhA, which lyses erythrocytes, increases iron levels and, indirectly, actives the production of RtxA1, which causes the death of the fish by a toxic sepsis. (5) Shedding bacteria to water. Diseased fish liberate bacteria to water. If water is rich in iron, bacteria can infect humans (zoonosis). (6) Biofilm formation and dispersion. Bacteria could be attached to surfaces (including fish mucosae) and to form biofilms under iron restriction. Under iron excess, bacteria will be dispersed from the biofilms as capsulated motile bacteria. Figure modified from Pajuelo et al. (2016).